NEOS Investment Management LLC Has $1.32 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

NEOS Investment Management LLC increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 28.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,183 shares of the company’s stock after buying an additional 2,483 shares during the period. NEOS Investment Management LLC’s holdings in Cardinal Health were worth $1,317,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in CAH. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health in the 4th quarter valued at $26,000. Promus Capital LLC bought a new position in shares of Cardinal Health in the fourth quarter worth $30,000. Lee Danner & Bass Inc. bought a new position in shares of Cardinal Health in the fourth quarter worth $35,000. Kentucky Trust Co acquired a new position in Cardinal Health in the fourth quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC lifted its position in Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after purchasing an additional 144 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CAH has been the topic of several recent analyst reports. Wells Fargo & Company raised their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. JPMorgan Chase & Co. upped their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research note on Tuesday, January 7th. Finally, Argus set a $148.00 price objective on Cardinal Health in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Trading Down 0.2 %

NYSE:CAH opened at $136.43 on Friday. The stock’s 50-day moving average is $128.36 and its 200-day moving average is $120.80. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $137.18. The stock has a market cap of $32.96 billion, a P/E ratio of 25.45, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.48%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s payout ratio is presently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.